photo
Speaker

Byoung Cheol Kang

VICE PRESIDENT, MIRIMGENE CO. LTD.
Incheon, Korea, Republic of
CTO in MirimGene
Head of Pharmaceutical Business, CosmaxPharma
Head of Development & BD Department, DongWha Pharm
Project Manager, C&R Research
Product Manager, Janssen Korea, Johnson & johnson
R&D Manager, Stiefel Korea
Adjunct Professor, College of Pharmcy, Yonsei University
Adjunct Professor, College of Pharmcy, Ajou University
Ph.D. and Pharmacist
Technology Transfer Agent in Korea
Speaking In
10:45 AM - 11:00 AM (PDT)
Tuesday, June 14
MirimGene’s target of focus includes WARS among human aminoacyl-tRNA synthetases (ARSs). Especially…